75
Participants
Start Date
January 31, 2006
Primary Completion Date
September 30, 2009
Study Completion Date
July 31, 2013
MDX-010
selected dose administered IV every 3 weeks
Memorial Sloan-Kettering Cancer Center, New York
The Angeles Clinic and Research Institute, Los Angeles
Carolina BioOncology Institute, Huntersville
Henry Ford Medical Center-Fairlane, Dearborn
Josephine Ford Cancer Center-Downriver, Brownstown
Henry Ford Medical Center-West Bloomfield, West Bloomfield
Washington University School of Medicine, St Louis
The Angeles Clinic and Research Institute, Los Angeles
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Seattle Cancer Care Alliance, Seattle
University of Washington Medical Center, Seattle
Yale University School of Medicine, New Haven
Henry Ford Hospital, Detroit
Oregon Health and Science University, Portland
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY